Parkinson Canada
October Webinar - WebSocial (700 x 500 px)
During our October webinar, "Duodopa and Vyalev: Pump Therapies
for Parkinson's" Dr. Aakash Shetty discussed Duodopa and
Vyalev infusion therapies for individuals with Parkinson's,
including how each treatment works, eligibility criteria, pump
attachment procedures, practical aspects of use and maintenance,
medication storage and more.
VIEW THE RECORDING
[link removed]
ACCESS THE PRESENTATION
[link removed]
More information and support
Here are some additional resources on pump therapies and other
Parkinson's treatment options:
Parkinson Canada blog post on Vyalev (foslevodopa/foscarbidopa)
[link removed]
Davis Phinney Foundation's blog post on Duodopa (levodopa/carbidopa
enteral suspension)
[link removed]
Parkinson Canada Treatments for Parkinson's webpage.
[link removed]
Get involved
*
Read Parkinson Canada's latest report, "The Economic
Burden of Parkinson's in Canada," to understand the true
impact and send a letter to your government to demand change at
parkinsonspricetag.ca
[link removed]
*
Interested in volunteering? Apply and learn more here
[link removed]
Information and Referral Helpline L
[link removed]
Parkinson Canada's Information and Referral team is available
weekdays to answer your questions about Parkinson's or care
partnering, and can provide you with information in electronic or
hard copy formats.
Parkinson Canada is happy to offer education materials programs such
as this webinar and the Every Victory Counts® manual for
Canadians at no cost to the Parkinson's community thanks to the
generosity of our wonderful donors. Please visit parkinson.ca for
more information, to get involved or to support Canadians affected by
Parkinson's by
[link removed]
making a donation.
parkinson.ca |
[email protected]
Toll-free: 1-800-565-3000
Donate: [link removed]
Facebook: [link removed]
Twitter: [link removed]
Instagram: [link removed]
LinkedIn: [link removed]
YouTube: [link removed]
Website: [link removed]
© 2023 Parkinson Canada
Privacy policy: [link removed]
Unsubscribe: [link removed]